Immunotherapy: OFF-THE-SHELF PARTIAL HLA MATCHING SARS-COV-2 ANTIGEN SPECIFIC T CELL THERAPY FOR SEVERE COVID-19 PATIENTS

Detalles Bibliográficos
Autores principales: Kim, N., Im, K., Lee, J., Lee, D., Jekarl, D., Oh, E., Cho, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society for Cell & Gene Therapy. Published by Elsevier Inc. 2023
Materias:
POSTER ABSTRACTS: Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171022/
http://dx.doi.org/10.1016/S1465-3249(23)00587-X
_version_ 1785039342928920576
author Kim, N.
Im, K.
Lee, J.
Lee, D.
Jekarl, D.
Oh, E.
Cho, S.
author_facet Kim, N.
Im, K.
Lee, J.
Lee, D.
Jekarl, D.
Oh, E.
Cho, S.
author_sort Kim, N.
collection PubMed
description
format Online
Article
Text
id pubmed-10171022
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher International Society for Cell & Gene Therapy. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-101710222023-05-10 Immunotherapy: OFF-THE-SHELF PARTIAL HLA MATCHING SARS-COV-2 ANTIGEN SPECIFIC T CELL THERAPY FOR SEVERE COVID-19 PATIENTS Kim, N. Im, K. Lee, J. Lee, D. Jekarl, D. Oh, E. Cho, S. Cytotherapy POSTER ABSTRACTS: Immunotherapy International Society for Cell & Gene Therapy. Published by Elsevier Inc. 2023-05 2023-05-10 /pmc/articles/PMC10171022/ http://dx.doi.org/10.1016/S1465-3249(23)00587-X Text en Copyright © 2023 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle POSTER ABSTRACTS: Immunotherapy
Kim, N.
Im, K.
Lee, J.
Lee, D.
Jekarl, D.
Oh, E.
Cho, S.
Immunotherapy: OFF-THE-SHELF PARTIAL HLA MATCHING SARS-COV-2 ANTIGEN SPECIFIC T CELL THERAPY FOR SEVERE COVID-19 PATIENTS
title Immunotherapy: OFF-THE-SHELF PARTIAL HLA MATCHING SARS-COV-2 ANTIGEN SPECIFIC T CELL THERAPY FOR SEVERE COVID-19 PATIENTS
title_full Immunotherapy: OFF-THE-SHELF PARTIAL HLA MATCHING SARS-COV-2 ANTIGEN SPECIFIC T CELL THERAPY FOR SEVERE COVID-19 PATIENTS
title_fullStr Immunotherapy: OFF-THE-SHELF PARTIAL HLA MATCHING SARS-COV-2 ANTIGEN SPECIFIC T CELL THERAPY FOR SEVERE COVID-19 PATIENTS
title_full_unstemmed Immunotherapy: OFF-THE-SHELF PARTIAL HLA MATCHING SARS-COV-2 ANTIGEN SPECIFIC T CELL THERAPY FOR SEVERE COVID-19 PATIENTS
title_short Immunotherapy: OFF-THE-SHELF PARTIAL HLA MATCHING SARS-COV-2 ANTIGEN SPECIFIC T CELL THERAPY FOR SEVERE COVID-19 PATIENTS
title_sort immunotherapy: off-the-shelf partial hla matching sars-cov-2 antigen specific t cell therapy for severe covid-19 patients
topic POSTER ABSTRACTS: Immunotherapy
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171022/
http://dx.doi.org/10.1016/S1465-3249(23)00587-X
work_keys_str_mv AT kimn immunotherapyofftheshelfpartialhlamatchingsarscov2antigenspecifictcelltherapyforseverecovid19patients
AT imk immunotherapyofftheshelfpartialhlamatchingsarscov2antigenspecifictcelltherapyforseverecovid19patients
AT leej immunotherapyofftheshelfpartialhlamatchingsarscov2antigenspecifictcelltherapyforseverecovid19patients
AT leed immunotherapyofftheshelfpartialhlamatchingsarscov2antigenspecifictcelltherapyforseverecovid19patients
AT jekarld immunotherapyofftheshelfpartialhlamatchingsarscov2antigenspecifictcelltherapyforseverecovid19patients
AT ohe immunotherapyofftheshelfpartialhlamatchingsarscov2antigenspecifictcelltherapyforseverecovid19patients
AT chos immunotherapyofftheshelfpartialhlamatchingsarscov2antigenspecifictcelltherapyforseverecovid19patients

Ejemplares similares